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Ischaemia-Reperfusion Injury and Regional Inflammatory
Responses in Abdominal Aortic Aneurysm Repair
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Department of Vascular Surgery, University of Leicester, Leicester UK
Objectives. The inflammatory response to abdominal aortic aneurysm repair is likely to result in response to an ischaemia-
reperfusion injury (IRI) to the lower-limbs and gastrointestinal tract. This paper reviews the pathogenesis of the
inflammatory response to abdominal aortic aneurysm repair, with specific reference to the levels of evidence in the current
literature regarding the potential origin of the inflammatory response.
Design. Review article.
Methods. The current literature (1966 to August 2003) was reviewed specifically for all articles employing techniques of
regional blood sampling from the venous drainage of the lower limbs or gastrointestinal tract during abdominal aortic
aneurysm repair.
Results. Ten relevant studies were identified. These demonstrated that regional blood sampling techniques could be easily
performed, and provided useful information regarding the potential sites of origin of the inflammatory response.
Conclusions. Regional blood sampling techniques provide useful information regarding the potential sites of origin of the
inflammatory response. Current evidence suggests that both the lower limbs and gastrointestinal tract are clearly important
in their roles, however more work is now required to compare directly the roles and contributions of the lower limbs and
gastrointestinal tract to the inflammatory response during abdominal aortic aneurysm repair.
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Introduction
Abdominal aortic aneurysms (AAAs) are common,
with an estimated prevalence of 3% in men above the
age of 50 years,1 – 3 accounting for approximately 2% of
deaths in men over the age of 65 years.4 Identification
of non-ruptured AAAs allows successful, elective
operative intervention with an associated mortality
of 5%, attributed largely to cardiac causes.5 Repair of a
ruptured AAA is a surgical emergency with an
estimated mortality of 50%, with most deaths occur-
ring from subsequent multiple organ failure (MOF)6,7
post-operatively.
MOF should be regarded as the endpoint of a
patient’s physiological spectrum from that of a well
patient with no physiological derangement on the one
hand, to that of a critically ill patient requiring organ
support at the other extreme. Within this wide
physiological spectrum exists the systemic inflamma-
tory response syndrome (SIRS) (Table 1). SIRS is really
the first step in the progression to MOF and results
from the activation of inflammatory pathways, being
largely mediated by cytokines such as interleukin-1
(IL-1), interleukin-6 (IL-6) and tumour necrosis
factor-a (TNF-a).
The reason to account for the large and sustained
systemic inflammatory response in ruptured AAA
patients, and the subsequent high incidence of post-
operative organ failure is as yet not fully explained.
The most widely accepted hypothesis why patients
with ruptured aneurysms have a much less favourable
outcome compared to elective patients is that they
are subjected to two or more insults of ischaemia-
reperfusion injury (IRI) rather than one; also referred
to as the ‘second-hit’ phenomenon. In addition to the
IRI caused by the aortic clamp, patients with ruptured
aneurysms are also subjected to varying degrees of
IRI as a result of periods of hypotension and
hypovolaemic shock, secondary to intraperitoneal
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and retroperitoneal haemorrhage. Patients with rup-
tured aneurysms also experience greater degrees of
acidosis, hypothermia, blood transfusion and longer
clamp times.
With regard to the IRI common to both elective and
rupture patients (i.e. that caused by aortic clamping),
controversy exists over which particular tissues are
most susceptible to periods of ischaemia and reper-
fusion, and which tissues are most likely to be
responsible for the initial inflammatory response.
The two main areas in question are the gastrointestinal
tract (which is subjected to trauma as a result of small
bowel handling in addition to ischaemia and reper-
fusion), and the muscle-mass of the lower-limbs.
Various studies have implicated both of these regions
as the potential origin of the inflammatory response in
infrarenal AAA repair, however, much of the data so
far appears conflicting.
This article will provide an overview of the
inflammatory responses involved in AAA repair, and
a brief summary of the cellular effects of IRI. This will
be followed by a review of the current levels of
evidence for the likely origin of the SIRS and MOF in
patients after AAA repair. This is an important
question, as determining the anatomical origin of
SIRS and MOF may enable the development of
targeted therapy with the aim of improving the
mortality from MOF in patients with ruptured
aneurysms.
Methods
In order to determine levels of evidence for the origin
of SIRS and MOF in patients with AAA, a literature
search was conducted using MEDLINE (1966–August
2003) and EMBASE (1980 – August 2003) search
engines. Keywords used as single or combined
searches included ‘abdominal aortic aneurysm’,
‘lower limbs’, ‘gastrointestinal tract’, ‘ischaemia’,
‘reperfusion’, ‘inflammation’, ‘SIRS’ and ‘MODS’.
Articles were examined for their relevance to the
particular question, and original papers describing
regional blood and tissue sampling were included.
Articles in languages other than English were
excluded. Articles of relevance that were not held in
local libraries were requested from national libraries.
Published abstracts from national meeting and rele-
vant cross-referenced articles were also included.
The inflammatory responses to AAA repair
The inflammatory response involves the activation of a
number of inflammatory pathways. These include
mediators generated from components of blood (the
kinin, complement and clotting cascades) and inflam-
matory mediators of tissue and cellular origin (hista-
mine, cytokines and the lipid-derived mediators:
prostaglandins, leukotrienes, thromboxanes and plate-
let activating factor (PAF)). The inflammatory
response also involves the activation of the immune
system (namely neutrophils) and the vascular
endothelium.
In patients undergoing AAA repair, the inflamma-
tory response has been well documented, and there
has been a large amount of research investigating
these inflammatory responses in both the elective and
emergency settings. These responses are examined
below.
Complement
The complement system is composed of a number of
components (proteins) present in plasma, which are
involved in the mediation of inflammation and
humoral immunity. Activated complement com-
ponents have a number of important effects. These
include bacterial lysis (complement complex C5b6789)
and opsonisation (C3), mast cell degranulation and
neutrophil chemotaxis (C5a), and smooth muscle
contraction resulting in increased vascular per-
meability (C3a and C5a).
Complement activation has been shown to occur
during AAA repair, with the length of time of aortic
cross-clamping correlating well with the increase in
plasma levels of C3a and C5a.8 Other studies
investigating the response of the complement system
have produced similar findings.9 – 11
Coagulation and fibrinolysis
Changes in the coagulation cascades have been
demonstrated to occur as a result of AAA repair. It is
not clear, however, whether AAA repair results in a
predominantly prothrombotic/procoagulant state, or
a predominantly fibrinolytic state. Adam et al.12
demonstrated a largely procoagulant state in patients
undergoing repair of both elective and ruptured
Table 1. Definition of SIRS
SIRS is defined by the presence of $2 of the following criteria:
A white cell count of .12,000 cells/mm3, or ,4000 cells/mm3, or
.10% immature (band) forms
A temperature of .38 or ,36 8C
A heart rate of .90 beats per minute
A respiratory rate of .20 breaths per minute, or PaCO2 ,4.3 kPa
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infrarenal AAAs. These changes were especially
marked in patients with ruptured aneurysms.
Anagnostopoulos et al.13 in a study investigating
supracoeliac cross-clamping in pigs, also demon-
strated a procoagulant state, as did a study on
human subjects by Holmberg et al.14 In contradiction
to these three papers, however, Illig et al.15 found that
patients undergoing supracoeliac clamping for
thoracoabdominal aneurysm repair developed a pro-
fibrinolytic state within 20 min of aortic clamping.
These conflicting data require further investigation, as
the first two studies would suggest the use of systemic
heparin in rupture patients might be of benefit,
whereas data from the third study suggests a possible
role for antifibrinolytic agents in these patients.
Kinins
The kinin system is a further group of plasma-derived
inflammatory mediators. In common with the coagu-
lation and fibrinolytic systems, the kinin system is also
activated by Hageman Factor (Factor XII). Bradykinin
is the main product of the kinin pathway, and causes
increased vascular permeability, arteriolar dilatation
and pain. To date, products of the kinin pathway such
as bradykinin have not been investigated in patients
undergoing AAA repair.
Cellular and tissue mediators of the inflammatory response
Inflammatory mediators of tissue and cellular origin
have been extensively studied. Of these, the cytokines
have received most interest. Cytokines are a family of
glycoproteins that serve as chemical messengers
between cells, and are involved in processes such as
cell growth and differentiation, tissue repair and
remodelling, and regulation of the immune
response.16 Usually, cytokines exert their effects in an
autocrine or paracrine fashion. However, if cytokine
production is excessive, they may have endocrine or
systemic effects,17 resulting in the SIRS.18 In addition
to inflammatory effects, a number of cytokines exert
anti-inflammatory effects. The key cytokines involved
in IRI, the response to trauma and the mediation of
SIRS and organ failure are listed in Table 2, with their
cell of origin and main effects summarised.
During sepsis and SIRS, cytokines are produced in a
sequential fashion or cascade, with specific cytokines
appearing either early or late in the cascade. Cytokines
appearing early include TNF-a and interleukin 1b
(IL-1b), with the cytokines interleukin 6 (IL-6) and
interleukin 8 (IL-8) subsequently released.17 Cytokines
are not stored within cells, rather being newly
synthesised in response to inflammatory stimuli.
AAA repair has been shown to be associated with
an increase in the levels of both inflammatory and anti-
inflammatory cytokines. The most commonly studied
cytokines are IL-1b, IL-6, TNF-a (pro-inflammatory),
IL-8 (chemotactic pro-inflammatory) and IL-10 (anti-
inflammatory).
IL-6 has been shown to increase in plasma during
AAA repair, and remains elevated in the post-
operative period.11,19,21 – 29 TNF-a has also been
measured as a marker of the cytokine response to
AAA repair. The results, however, have been conflict-
ing, with some authors showing no change in TNF-a
levels,19,20,22,30,31 and others demonstrating a rise in
plasma TNF-a.11,23,27 TNF-a has been shown to be
higher in shocked patients with ruptured AAA and in
those that died.23 Hill et al.31 observed that whilst there
was no measurable change in TNF-a levels in AAA
patients with infrarenal clamps, patients with supra-
renal clamps did have a small but significant increase
in TNF-a. IL-8 has been less commonly measured but
does appear to increase during and shortly after AAA
repair.11,23,30,32 IL-1b has been shown to transiently
increase during AAA repair,20 although other
researchers have failed to show any increase.22 The
anti-inflammatory cytokine IL-10 has been assayed in
a number of studies, with the majority demonstrating
an increase in IL-10 levels during surgery.19,28,30,33
Lipid mediators
Lipid mediators of the inflammatory response have
received some interest in patients undergoing AAA
repair. They are derived from the metabolism of cell
membrane phospholipids. When metabolised, a num-
ber of active products are released, including PAF and
a number of compounds classed as eicosanoids.
During AAA repair, neutrophil leukotriene-B4
(LTB4) has been demonstrated to increase significantly
during the procedure, and has been shown to
markedly increase in cases where long aortic clamp
times were required.34 Thromboxane-B2 (TxB2) has
also been shown to increase during AAA repair,24,35
although others have not seen similar effects.36,37
Thromboxane-A2 (TxA2), Prostaglandin-I2, (PGI2)
and 6-keto-prostaglandin-F1 (6-K-PGF1) have also
been seen to increase during AAA repair.36,38
Histamine
No significant changes in systemic histamine levels
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have been demonstrated, but this has only been
investigated in two studies.36,39
Cellular immune responses
The responses of immune cells to AAA repair have
largely concentrated on the role of the neutrophil
polymorph. As part of the inflammatory response,
neutrophils become ‘activated’ thus allowing them to
be recruited to sites of cellular injury. Activated
neutrophils then propagate the inflammatory response
locally, as well as being recruited to other sites such
as the lungs where they may be involved in the
development of acute lung injury (ALI). As neutro-
phils are activated, they modulate their expression of
cell membrane integrins, expressing a greater number
of the CD11b/CD18 integrin complexes (also known
as the CR3 integrin due to its complement-binding
properties). These are involved in cell binding,
allowing activated neutrophils to bind to endothelium
via the endothelial adhesion molecules ICAM-1 and
ICAM-2, thus allowing neutrophils to exert their
effects locally. Research in AAA surgery has demon-
strated an increase in neutrophil CD11b expression
both in vitro35,40 and in vivo.41
Endothelium
Evidence of vascular endothelial activation has also
been documented during AAA repair. Venous blood
taken during the reperfusion stage of AAA repair
has been shown to cause upregulation of endothelial
cell ICAM-1 expression in vitro.35 Endothelial cell
membrane integrins that have been shed from the
cell surface have also been demonstrated in AAA
patients, with especially high levels of soluble ICAM-1
in shocked AAA patients and in non-survivors of
ruptured AAA, suggesting greater levels of endo-
thelial activation.23
Reactive oxygen species (ROS)
Oxygen free radical (OFR) production as a response to
the IRI experienced by AAA patients has also been
documented. Thompson et al.42 demonstrated the
production of OFRs in patients undergoing both
conventional and endovascular repair of AAA. The
OFR generation was maximal after 5 min of lower-
limb reperfusion, declining after 30 min of reper-
fusion. OFR generation was lower in the endovascular
group, although this did not reach statistical signifi-
cance. In comparison, Formigli et al.43 were unable to
demonstrate any superoxide anion (O2
2) production in
AAA patients. This may be due to the experimental
technique used and the inherent instability of OFR
species. An alternate method of demonstrating OFR
release is by measurement of the by-products of
OFR-mediated injury. OFRs attack lipid cell mem-
branes, leading to the production of by-products of
lipid peroxidation, namely malondialdehyde (MDA)
and F(2)-isoprostane which can both be used as
specific markers of lipid peroxidation. F(2)-isopros-
tane has been shown to be raised post-operatively in
patients undergoing AAA repair, especially in patients
undergoing repair of ruptured AAA. Rupture patients
were also shown to have a raised F(2)-isoprostane
level on arrival at hospital, indicating that patients
Table 2. Key cytokines involved in ischaemia-reperfusion injury, the systemic inflammatory response and organ failure
Cytokine Cell of origin Effect
IL-1b Macrophage Endothelial activation
Neutrophil Fever
Endothelium Neutrophil release
IL-6 Macrophage Endothelial activation
Neutrophil Fever
Endothelium Neutrophil release
Monocytes Acute phase protein synthesis
IL-8 Macrophage Neutrophil chemoattraction and activation
Fibroblast
Endothelium
IL-10 Macrophages Inhibition of macrophage and T-cell function (anti-inflammatory)
T-cells
TNF-a Macrophage Endothelial activation
Neutrophil Nitric oxide synthesis
Fever
Neutrophil release
Neutrophil and macrophage activation and chemoattraction
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with ruptured AAAs are exposed to an additional
early oxidative injury.44 This provides good evidence
of the ‘two-hit’ phenomena hypothesised as occurring
in patients with ruptured AAA.
The identification of this generalised inflammatory
response experienced by AAA patients has lead to
much speculation over its origin and potential causes.
This has resulted in research being directed towards,
and concentrating on specific areas of the surgery and
disease process to demonstrate possible aetiologies for
this inflammatory response. Aneurysm patients and
rupture AAA patients in particular appear to be more
susceptible to SIRS and MOF when compared with
patients undergoing other major operations. The one
obvious factor in AAA repair that sets it aside from
most other intra-abdominal operations, is the necessity
for aortic clamping. Aortic clamping leads to an IRI of
all tissues distal to the aortic clamp; most notably the
lower-limbs and the inferior mesenteric artery (IMA)-
dependent region of the gastrointestinal tract. The
pathophysiology of IRI has been extensively exam-
ined, and is a well-documented means of inducing an
inflammatory response. Examining the cellular events
that occur during ischaemia and reperfusion may
suggest potential mechanisms by which the inflam-
matory response is activated, thus providing a good
insight into why AAA patients should experience such
a marked inflammatory response.
Ischaemia-Reperfusion Injury (IRI)
Ischaemia and reperfusion have profound effects on
the target tissues, resulting in an inflammatory
response. Tissue ischaemia results in anaerobic cellu-
lar metabolism, leading to localised lactic acidosis,
and decreased cellular glycogen and ATP levels. This
reduces cell membrane function causing cellular
swelling. Ischaemia also results in vascular endothelial
adhesion molecule upregulation, cytokine production
and activation of the kinin, complement and clotting
pathways. Importantly, ischaemia also results in
upregulation of the enzyme xanthine oxidase (XO).
When tissue reperfusion occurs, re-oxygenation leads
to OFR production. The presence of OFRs results in
lipid peroxidation, complement activation, arachi-
donic acid release (with subsequent eicosanoid syn-
thesis) and an increased endothelial adhesion
molecule synthesis. White cell activation and micro-
vascular dysfunction will also occur.
In summary, the effects of ischaemia and reper-
fusion at a cellular level are widespread (Fig. 1), thus
providing numerous mechanisms whereby an inflam-
matory response may be initiated. As described
earlier, the existence of a generalised and potentially
detrimental inflammatory response is well docu-
mented in AAA patients.
The exact origin of the inflammatory response to
AAA repair remains unclear and has led to the
investigation of IRI and inflammatory responses of
specific organs. As the IRI resulting from the aortic
clamp is the most likely precipitating factor in the
inflammatory response, research has now focused on
the tissues most at risk of damage by aortic clamping;
namely the lower-limbs and gastrointestinal tract. This
research has concentrated on the particular region by
either taking tissue biopsies from that region (e.g. from
the legs during AAA repair) or by sampling blood
from the venous system draining those regions. The
evidence for each of these sites as a source of the
inflammatory response to AAA repair is discussed
below. All human studies using regional sampling
techniques are summarised in Table 3.
The Lower-Limb as a Potentiator of the
Inflammatory Response in AAA Repair
Human studies of tissues subjected to ischaemia and
reperfusion have demonstrated evidence of cellular
damage, as well as both endothelial and white cell
activation. In a small cohort of patients undergoing
open AAA repair, in whom quadriceps muscle
biopsies were taken, Formigli et al.43 demonstrated
that ischaemia was associated with neutrophil infiltra-
tion of muscle, when compared with control samples
from the same patients, taken prior to aortic clamping.
Reperfusion was also associated with neutrophil
infiltration, but in addition it was also noted to be
associated with ultrastructural changes in the muscle
fibres, demonstrated with the use of electron micro-
scopy. During the same experiment, saphenous vein
blood sampling revealed an increase in the number of
circulating neutrophils and a decrease in circulating
levels of the complement components C3 and C5
(thought to represent complement consumption),
which was assumed to represent activation of the
immune and complement systems, respectively. This
was not demonstrated in corresponding venous
samples taken from the arm. The results of this study
are interesting, but are limited by the small sample size
and lack of formal patient controls.
Further research by the same group45 in another
cohort of AAA patients, took the histological exami-
nations a step further in order to investigate the role of
the vascular endothelium in response to ischaemia and
reperfusion. Using immunohistochemical techniques,
the presence of E-selectin upregulation (a marker of
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endothelial activation) during ischaemia was demon-
strated when compared to control samples from the
same patients prior to aortic clamping. Neutrophil
accumulation was also demonstrated to reflect the
degree of E-selectin expression. Again, this study is
limited by its small sample size and lack of indepen-
dent patient controls. It is conceivable that a long
operation per se, may be associated with E-selectin
expression in the legs, and not directly due to the
effects of ischaemia.
In a subsequent paper looking at the protective
effects of vitamin E on human skeletal muscle IRI,46
ischaemia alone in AAA patients was found to
increase neutrophil infiltration of muscle fibres, but
Fig. 1. Summary of the cellular effects of ischaemia and reperfusion.
Table 3. Studies identified employing regional sampling techniques
Author Region sampled Substance measured Outcome
Formigli L43 1. Saphenous vein Complement (C3 and C4) FV , systemic
2. Systemic Neutrophils FV . systemic
3. Muscle biopsy (quadriceps) Superoxide No difference
Muscle neutrophil infiltration Neutrophil infiltration of muscle during
ischaemia and reperfusion
Muscle morphology Altered muscle morphology during reperfusion
Formigli L45 Muscle biopsy (quadriceps) Muscle E-selectin expression " E-selectin and neutrophil infiltration of
muscle during ischaemia and reperfusion
Muscle neutrophil infiltration
Novelli GP46 Muscle biopsy (quadriceps) Muscle MDA content " Muscle MDA content, neutrophil infiltration,
oedema and mitochondrial swelling with
reperfusion
Muscle morphology
Rowlands TE47 1. FV IL-6 FV . systemic IL-6
2. Systemic IL-8 FV . systemic IL-8
IL-10 No difference in IL-10
Thompson MM42 FV only OFR Systemic samples not taken for
comparison
IL-1b
TNF-a
IL-6
Holmberg A28 1. FV IL-6 No difference
2. Systemic IL-10 No difference
Fibrinogen No difference
MCP-1 No difference
sIL-2R FV . systemic
Cabie A54 1. PV TNF-a PV . systemic TNF-a
2. Systemic L-6 No difference
Endotoxin No difference
Baigrie RJ58 (Abstract) 1. IMV IL-6 IMV . systemic IL-6
2. Systemic Endotoxin (ET) No difference
Green M61 (Abstract) 1. IMV IL-6 IMV . systemic IL-6
2. Systemic
Lau LL59 1. PV Endotoxin (ET) No difference
2. Systemic
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was not associated with a significant increase in
muscle MDA production (assessed using muscle
homogenates). Reperfusion was associated with both
neutrophil infiltration and MDA production, assumed
to result from neutrophil production of reactive
oxygen species in response to reperfusion. This
provides in vivo evidence to confirm that the majority
of lipid peroxidation occurs during reperfusion, and
that oxidative stress is occurring within the lower-limb
musculature. Novelli et al.46 also demonstrated a
reduction in neutrophil infiltration and muscle MDA
production in patients treated preoperatively with
vitamin E, suggesting a possible role for the use of
antioxidants in patients subjected to IRI.
Human studies investigating the biochemical para-
meters of inflammation in IRI are more widespread.
However, studies concentrating on the contribution
of the lower-limbs, as assessed by regional blood
sampling from the venous outflow from the lower
limbs are less common.
Rowlands et al.,47 in a study of patients undergoing
open repair (OR) and endovascular repair (ER) of
AAAs, examined cytokine levels in systemic and
femoral venous blood as markers of inflammation.
They demonstrated a significant increase in pro-
inflammatory cytokine release (IL-6, IL-8) in femoral
blood samples during reperfusion in OR patients.
Significant differences between cytokine levels in
femoral and systemic venous blood were also
observed, with levels in the femoral vein being much
higher than systemic samples. This was extrapolated
to implicate the legs as providing a significant
contribution to the overall inflammatory response by
their production of pro-inflammatory cytokines.
In a small study of 12 AAA patients undergoing
either endovascular or open repair of AAA,42 femoral
vein blood sampling demonstrated a significant
reduction in IL-1b and TNF-a in the endovascular
group, but no difference in OFR or IL-6 concentrations.
No systemic samples were taken for comparison,
however, and therefore it is difficult to infer that the
cytokines were being produced in the legs.
Not all researchers agree that local blood sampling
for cytokines is likely to be informative. In a study of 11
patients undergoing open AAA repair, Holmberg
et al.28 found no difference in intraoperative IL-6 or
IL-10 levels between systemic and femoral venous
blood samples. From these results, they inferred that
there was no local cytokine response in tissue distal to
the aortic clamp. If this were the case, one may expect
very low levels of cytokines in femoral blood samples
during ischaemia, and these figures are more likely to
be a feature of the small sample size of the study. It is
also conceivable that they may have inadvertently
sampled blood from the femoral artery rather than the
femoral vein.
The Gastrointestinal Tract as a Potentiator of the
Inflammatory Response in AAA Repair
There are a number of potential mechanisms by which
the gastrointestinal tract can contribute to the overall
inflammatory response in AAA repair. These include
trauma (as a result of bowel manipulation, intestinal
hypothermia and mesenteric traction), ischaemia
(secondary to altered blood flow as a result of the
above, in addition to the effects of aortic clamping) and
endotoxin translocation. Of these three, the effect of
endotoxin translocation has been most extensively
studied, and is frequently implicated as the cause of
organ failure after AAA repair. All of these factors will
now be examined individually.
Ischaemia and reperfusion
The effects of ischaemia and reperfusion on the
gastrointestinal tract, and the subsequent impact
upon the inflammatory response has received con-
siderable interest. Much of the data are however
conflicting, and the exact role of the gut within the
overall inflammatory response remains to be defined.
In AAA repair, ischaemia and reperfusion can occur
for a number of reasons. This is either due to direct
ligation of vessels (e.g. the IMA), or due to mesenteric
traction, bowel hypothermia or as a result of the
release of vasoactive mediators from the vascular
endothelium within the gastrointestinal tract.
Direct ligation of the IMA as a cause of colonic
ischaemia remains a controversial subject. Common
sense would suggest that an occluded IMA (by either
atherosclerotic changes or thrombus within the sac)
would have no contribution to colonic perfusion.
Equally, an IMA that back-bleeds profusely suggests
good collateral circulation via the marginal artery and
internal iliac vessels. Ligation of the IMA in both of
these situations would seem irrelevant. An area of
slightly more debate is the IMA with a low stump
pressure.48 The majority of evidence, however, would
suggest that IMA ligation does not relate to colonic
ischaemia,49,50 and that in any case, the relationship
between lesser degrees of colonic ischaemia and
clinical outcome is not clear.51 One further point of
interest is that IMA occlusion will usually occur as a
result of endovascular repair (ER), yet ER has been
implicated as having a lower incidence of colonic
ischaemia.29 This may suggest that internal iliac
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occlusion could be a more significant event, as has
previously alluded to by Bjork et al.52
In addition to the cellular effects of ischaemia
and reperfusion that are similar to those described
for the legs (e.g. inflammatory mediator release,
endothelial and white cell activation), an IRI to the
gastrointestinal tract will also lead to changes in
mucosal permeability,53 which risks subsequent endo-
toxin translocation.
Intestinal manipulation and the inflammatory response
During open transperitoneal AAA repair, mesenteric
traction and cooling due to intestinal manipulation
will exacerbate intestinal ischaemia secondary to
vasoactive amine release and anatomical distortion
of small blood vessels. Specific parts of the intestine
may also be subjected to greater degrees of ischaemia
than others, as a result of aortic clamping (e.g. the
IMA-dependent colon/pelvic viscera), although the
precise contributions remain unquantified.
Endotoxin (ET)
In addition to direct activation of the inflammatory
response by IRI and trauma, the role of endotoxin and
bacterial translocation must also be considered as an
important indirect activator of the inflammatory
response, as migration of endotoxin from the gut
lumen into either venous or lymphatic channels has
the propensity to further activate the immune system.
The role of endotoxin has been repeatedly impli-
cated in the pathogenesis of SIRS following AAA
repair. Endotoxin (ET) has been demonstrated in the
blood and lymph of patients even prior to aortic
clamping, implicating the role of laparotomy alone as
a cause of endotoxin translocation.54 The reason for
this ET translocation is thought to be due to an
impaired mucosal barrier due to local factors such
as ischaemia, trauma and intestinal cooling. Endo-
toxaemia has also been demonstrated to occur as a
secondary phenomenon to lower-limb IRI in rats,55,56
and it has also been proposed that endotoxin may
enter the body during laparotomy via factors present
in air.57
The effects of endotoxaemia include white cell
activation, stimulation of cytokine release, comple-
ment activation, further increases in mucosal perme-
ability and activation of the clotting cascades. All of
these ET-mediated effects will further fuel the inflam-
matory response.
Research specifically concentrating on the
involvement of ischaemia and reperfusion on the
gastrointestinal tract is available, but human studies
are few in number, and mostly of small sample size.
There have been a number of animal experiments
investigating the role of limb ischaemia and reper-
fusion upon gastrointestinal permeability, suggesting
a possible route for endotoxin and/or bacterial
translocation, but these have largely failed to adopt
regional blood sampling as a tool for demonstration of
regional contributions to the inflammatory response.
These studies have essentially demonstrated that in
rats, isolated lower-limb IRI can result in cellular
structural changes within the mucosa of the gastroin-
testinal tract53 and systemic endotoxaemia.56
In comparison to animal studies, human studies
have more commonly employed regional sampling
techniques. In a group of patients undergoing open
AAA repair, Cabie et al.54 found high levels of TNF-a
in the portal vein (compared to systemic blood), and
speculated that this was due to cytokine induction by
bacterial endotoxin that had traversed the mucosal
barrier. This provides some evidence that the gastro-
intestinal tract may play an important role in the
generation of the inflammatory response. Portal
lipopolysaccharide (LPS) and IL-6 did not differ
significantly between portal and systemic blood, and
the lymphatic route was therefore implicated as being
important in ET translocation into the systemic
circulation. Baigrie et al.,58 however, in another study
sampling portal blood, found high levels of IL-6 in the
portal circulation compared to systemic samples.
Portal IL-6 levels rose during ischaemia alone, and
then increased further during reperfusion. Interest-
ingly, no correlation between portal IL-6 concen-
trations and the presence of endotoxin was found in
the portal circulation. This could either represent a
true lack of association or alternatively that endotoxin
was leaving the gastrointestinal tract via alternative
mechanisms such as the lymphatics; a hypothesis that
has previously been alluded to.54
In a further study of 14 patients undergoing both
transperitoneal and extraperitoneal AAA repair, Lau
et al.59 demonstrated endotoxaemia and altered gut
mucosal permeability in AAA repair patients prior to
aortic clamping. This suggests that handling and/or
cooling of the intestines may be implicated as a
contributing factor to endotoxin translocation,
especially since the antitoxin response was not
significant in patients undergoing AAA repair via an
extraperitoneal approach. They also question the
significance of the relationship between mucosal
permeability and endotoxaemia, as an increase in
permeability was not demonstrated until after the
significant increase in endotoxin concentrations.
Assessment of permeability, however, was performed
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using the lactulose/mannitol differential absorption
test, which may not be as sensitive when compared
with histological assessment.
In a study of 21 patients undergoing open AAA
repair, Soong et al.60 demonstrated a positive corre-
lation between acidosis (used as a basis for indication
of ischaemia) of the sigmoid colon and concentrations
of systemic endotoxin, TNF-a and IL-6. However,
endotoxin was also demonstrated in patients without
significant degrees of sigmoid acidosis, suggesting
that ET translocation may not be due to acidosis alone.
When extrapolated to outcome, there was no evidence
of impaired outcome with higher degrees of acidosis,
raising questions of clinical usefulness. Also, a control
group was not used to demonstrate the effects of
laparotomy alone on blood flow and endotoxin levels,
and furthermore only 50% of patients having the same
operation actually developed sigmoid ischaemia,
which suggests other factors may be important.
Green et al.61 demonstrated high levels of IL-6 (used
as a marker of tissue damage) in inferior mesenteric
vein (IMV) blood compared to systemic blood during
aortic clamping and reperfusion in 15 patients under-
going AAA repair. The increase in IL-6 was attributed
to sigmoid ischaemia (as assessed by mucosal pH of
the sigmoid colon), and the results were inferred to
implicate the colonic response to injury as driving the
systemic response. There was, however, no mention of
extrapolation to patient outcome, and no samples from
other parts of the gastrointestinal tract or ischaemia-
dependent regions were taken for comparison.
Welborn et al.30 in a study of thoracoabdominal
aneurysm repair, demonstrated significantly lower
levels of plasma TNF-a and IL-10 in patients with
left atrial-femoral bypass compared to those without,
and attributed this to a reduction in visceral ischaemic
time. The fact that the lower limb muscle bulk will also
be better perfused was not considered. Interestingly
they found that IL-6 levels were higher in the bypass
group. This may be a chance finding but could indicate
that ischaemia-reperfusion of different organs may
generate different cytokine responses.
Conclusions
IRI with a subsequent generalised inflammatory
response occurs in AAA repair. Both the gastro-
intestinal tract and lower limbs are clearly important
in their contribution to this inflammatory response in
AAA repair. It is however extremely difficult to
surmise which locality provides the most significant
contribution, and it may actually be difficult to directly
compare one region to another, as each region may
make contributions using different mechanisms and
thereby producing different inflammatory markers,
posing the question of which inflammatory marker to
measure. Furthermore, the substances released from
one region may affect another region thereby further
propagating the inflammatory response.
The contributions of each region are as yet
unquantified. Although studies have compared both
portal and femoral venous blood with systemic blood,
direct comparison of portal to femoral blood has not
been done. Previous authors have alluded to the fact
that cytokine detection may be difficult in peripheral
blood, and that the absence of a detectable level does
not exclude the local production of cytokines in
injured tissues. This theory would thus seem to favour
the argument for direct sampling where possible.
Further work is therefore needed to investigate the
comparative roles of the lower-limbs and gastro-
intestinal tract in the initiation of the inflammatory
response to AAA repair. This will allow any potential
future targeted therapies to be directed appropriately.
Methods of attenuating IRI and the subsequent
inflammatory responses experienced by patients
undergoing AAA are highly desirable in order to
reduce the morbidity and mortality associated with
AAA repair. Possible strategies can be viewed by their
location of action (e.g. those tackling the problem
either systemically or locally (targeted therapy)), or by
their timing of utilisation (e.g. intervening either
before, during or after the operation). To date, targeted
therapies have not received much interest. One
exception, however, is the concept of ischaemic
preconditioning. This was originally described in the
1980s by Murray et al.62 who observed that brief
periods of ischaemia prior to a prolonged period of
ischaemia provided some degree of protection against
the subsequent ischaemic injury. The applications of
this have so far clustered around cardiac IRI, organ
transplantation and free-pedicle tissue flaps used in
reconstructive surgery. However, interest is now
turning towards the field of limb salvage and vascular
surgery. Thus far, potential benefits have been demon-
strated in rodent and pig models of lower-limb
IRI,63 – 67 however, research in human models of aortic
surgery is still awaited.
Systemic treatments aimed at attenuating IRI and
the subsequent inflammatory responses have received
considerable interest in recent years. These treatments
can broadly be divided into antioxidant therapies, and
therapies targeting various mediators of inflammation
including cytokines, complement, neutrophils and the
endothelium. Antioxidant therapies are given prior to
the procedure, and aim to minimise cellular damage
resulting from OFRs. These therapies generally exploit
M. G. A. Norwood et al.242
Eur J Vasc Endovasc Surg Vol 28, September 2004
naturally occurring antioxidant systems such as super-
oxide dysmutase (SOD) and vitamin E (a-tocopherol).
Vitamin E has probably received most interest, and has
been shown in humans to reduce neutrophil accumu-
lation,68 MDA production, ultrastructural damage46
and muscle creatinine kinase production.69 Extrapol-
ation to clinical outcome is, however, less clear, and
recent human studies have failed to demonstrate
its use in reducing gastrointestinal permeability70
and renal microalbuminaemia.71
Other systemic therapies to have received recent
interest are the monoclonal antibodies directed at
vascular endothelial adhesion molecules (ICAM-1),72,73
neutrophil adhesion molecules (Mac-1),74,75 comple-
ment components76 and cytokines.77 Again, unfortu-
nately many of these therapies have had little benefit
in practice, which probably reflects the complex nature
of sepsis78 and IRI.79
References
1 Turk KAD. The post-mortem incidence of abdominal aortic
aneurysm. Proc R Soc Med 1965; 58:869–870.
2 Allen PIM, Gourevitch D, McKinley J, Tudway D, Goldman
M. Population screening for aortic aneurysms. Lancet 1987; ii:736.
3 Collin J, Aravjo J, Walton J, Lindsell D. Oxford screening
programme for abdominal aortic aneurysm in men aged 65–74.
Lancet 1988; 1:613–615.
4 St Leger AS, Spencely M, McCollim CN, Mossa M. Screening
for abdominal aortic aneurysm: a computer-assisted cost-utility
analysis. Eur J Vasc Endovasc Surg 1996; 11:183–190.
5 Anonymous, Mortality results for randomised controlled trial of
early elective surgery or ultrasonographic surveillance for small
abdominal aortic aneurysms. The UK Small Aneurysm Trial
Participants. Lancet 1998; 352:1649–1655.
6 Sayers RD, Thompson MM, Nasim A, Healey P, Taub N, Bell
PRF. Surgical management of 671 abdominal aortic aneurysms: a
13-year review from a single centre. Eur J Vasc Endovasc Surg 1997;
13:322–327.
7 Meesters RC, van der Graaf Y, Vos A, Eikelboom BC.
Ruptured aortic aneurysm: early postoperative prediction of
mortality using an organ system failure score. Br J Surg 1994; 81:
512–516.
8 Bengtson A, Lannsjo W, Heidemann M. Complement and
anaphylatoxin responses to cross-clamping of the aorta. Br J
Anaesth 1987; 59:1093–1097.
9 Swartbol P, Norgren L, Albrechtsson U et al. Biological
responses differ considerably between endovascular and con-
ventional aortic aneurysm surgery. Eur J Vasc Endovasc Surg 1996;
12:18–25.
10 Fosse E, Opdahl H, Sunde S, Aasen AO, Svennevig JL.
Granulocytes in bronchial lavage fluid after major vascular
surgery. Acta Anaesthesiol Scand 1987; 31:33–37.
11 Galle C, De Maertelaer V, Motte S et al. Early inflammatory
responses after elective abdominal aortic aneurysm repair: a
comparison between endovascular procedure and conventional
surgery. J Vasc Surg 2000; 32:234–246.
12 Adam DA, Ludlam CA, Ruckley CV et al. Coagulation and
fibrinolysis in patients undergoing operation for ruptured and
nonruptured infrarenal abdominal aortic aneurysm. J Vasc Surg
1999; 30:641–650.
13 Anagnostopoulos PV, Shepard AD, Pipinos II et al.
Haemostatic alterations associated with supracoeliac aortic
cross clamping. J Vasc Surg 2002; 35:100–108.
14 Holmberg A, Siegbahn A, Westman B, Bergqvist D. Ischaemia
and reperfusion during open abdominal aortic aneurysm surgery
induce extensive thrombin generation and activity. Eur J Vasc
Endovasc Surg 1999; 18:11–16.
15 Illig KA, Green RM, Ouriel K et al. Primary fibrinolysis during
supracoeliac aortic clamping. J Vasc Surg 1997; 25:244–251.
16 Oberholzer A, Oberholzer C, Moldawer LL. Cytokine
signalling—regulation of the immune response in normal and
critically ill states. Crit Care Med 2000; 28:N3–N12.
17 Blackwell TS, Christman JW. Sepsis and cytokines: current
status. Br J Anaesth 1996; 77:110–117.
18 Bone RC. Towards a theory regarding the pathogenesis of the
systemic inflammatory response syndrome: What we do and do
not know about cytokine regulation. Crit Care Med 1996; 24:
163–172.
19 Holzheimer RG, Gross J, ScheinM. Pro- and anti-inflammatory
cytokine-response in abdominal aortic aneurysm repair: a clinical
model of ischaemia-reperfusion. Shock 1999; 11:305–310.
20 Baigrie RJ, Lamont PM, Kwiatkowski D, DallmanMJ, Morris
PJ. Systemic cytokine response after major surgery. Br J Surg 1992;
79:757–760.
21 Baigrie RJ, Lamont PM, DallmanM, Morris PJ. The release of
interleukin-1 beta (IL-1) precedes that of interleukin 6 (IL-6) in
patients undergoing major surgery. Lymphokine Cytokine Res 1991;
10:253–256.
22 Ziegenfuss T, Wanner GA, Grass C et al. Mixed agonistic–
antagonistic cytokine response in whole blood from patients
undergoing abdominal aortic aneurysm repair. Intensive CareMed
1999; 25:279–287.
23 Froon AHM, Greve J-WM, Van Der Linden CJ, BuurmanWA.
Increased concentrations of cytokines and adhesion molecules in
patients after abdominal aortic aneurysm. Eur J Surg 1996; 162:
287–296.
24 Lammers KM, Innocenti G, Venturi A et al. The effect of
transient intestinal ischaemia on inflammatory parameters. Int J
Colorectal Dis 2003; 18:78–85.
25 Bolke E, Jehle PM, Storck M et al. Endovascular stent-graft
placement versus conventional open surgery in infrarenal aortic
aneurysm: a prospective study on acute phase response and
clinical outcome. Clinica Chemica Acta 2001; 314:203–207.
26 Komori K, Ishida M, Matsumoto T et al. Cytokine patterns and
the effects of a preoperative steroid treatment in patients with
abdominal aortic aneurysms. Int Angiol 1999; 18:193–197.
27 Elmarasy NM, Soong CV, Walker SR et al. Sigmoid ischaemia
and the inflammatory response following endovascular
abdominal aortic aneurysm repair. J Endovasc Ther 2000; 7:21–30.
28 Holmberg A, Bergqvist D, Westman B, Siegbahn A. Cytokine
and fibrinogen response in patients undergoing open abdominal
aortic aneurysm surgery. Eur J Vasc Endovasc Surg 1999; 17:
294–300.
29 Syk I, Brunkwall J, Ivancev K et al. Postoperative fever, bowel
ischaemia and cytokine response to abdominal aortic aneurysm
repair—a comparison between endovascular and open surgery.
Eur J Vasc Endovasc Surg 1998; 15:398–405.
30 Welborn MB, Oldenburg HSA, Hess PJ et al. The relationship
between visceral ischaemia, proinflammatory cytokines, and
organ injury in patients undergoing thoracoabdominal aortic
aneurysm repair. Crit Care Med 2000; 28:3191–3197.
31 Hill GE, Mihalakakos PJ, Spurzem JR, Baxter TB. Supraceliac,
but not infrarenal, aortic cross-clamping upregulates neutrophil
integrin CD11b. J Cardiothorac Vasc Anesth 1995; 9:515–518.
32 Parodi JC, Ferreira LM, Fornari MC, Berardi VE, Diez RA.
Neutrophil respiratory burst activity and pro- and anti-inflam-
matory cytokines in AAA surgery: conventional versus endo-
luminal treatment. J Endovasc Ther 2001; 8:114–124.
33 Oldenburg HS, Burress Welborn M, Pruitt JH et al.
Interleukin-10 appearance following thoraco-abdominal and
abdominal aortic aneurysm repair is associated with the duration
of visceral ischaemia. Eur J Vasc Endovasc Surg 2000; 20:169–172.
Regional Inflammatory Responses in AAA Repair 243
Eur J Vasc Endovasc Surg Vol 28, September 2004
34 Gadaleta D, Fantini GA, Silane MF, Davis JM. Neutrophil
leukotriene generation and pulmonary dysfunction after
abdominal aortic aneurysm repair. Surgery 1994; 116:847–852.
35 Barry MC, Wang JH, Kelly C, Sheehan S, Redmond HP,
Bouchier-Hayes D. Plasma factors augment neutrophil and
endothelial cell activation during aortic surgery. Eur J Vasc
Endovasc Surg 1997; 13:381–387.
36 Gottlieb A, Skrinska VA, O’Hara P, Boutros AR, Melia M,
Beck GJ. The role of prostacyclin in the mesenteric traction
syndrome during anaesthesia for abdominal aortic reconstruc-
tive surgery. Ann Surg 1989; 209:363–367.
37 Gabriel A, Werba A, Mares P et al. Influence of prostaglandin
E1 on tissue ischaemia during surgical repair of the abdominal
aorta. J Cardiothorac Vasc Anesth 1996; 10:201–206.
38 Lewin J, Swedenborg J, Egberg N, Vesterqvist O, Green K.
Effect of salicylic acid on increased production of thromboxane
after aortic graft surgery. Eur J Vasc Endovasc Surg 1989; 3:
213–218.
39 Duda D, Lorenz W, Celik I. Histamine release in mesenteric
traction syndrome during abdominal aortic aneurysm surgery:
prophylaxis with H1 and H2 antihistamines. Inflamm Res 2002;
51:495–499.
40 Swartbol P, Norgren L, Parsson H, Truedsson L. Endovas-
cular abdominal aortic aneurysm repair induces significant
alterations in surface adhesion molecule expression on donor
white blood cells exposed to patient plasma. Eur J Vasc Endovasc
Surg 1997; 14:48–59.
41 Barry MC, Kelly C, Burke P, Sheehan S, Redmond HP,
Bouchier-Hayes D. Immunological and physical responses to
aortic surgery: effect of reperfusion on neutrophil and monocytes
activation and pulmonary function. Br J Surg 1997; 84:513–519.
42 Thompson MM, Nasim A, Sayers RD et al. Oxygen free radical
and cytokine generation during endovascular and conventional
aneurysm repair. Eur J Vasc Endovasc Surg 1996; 12:70–75.
43 Formigli L, Lombardo LD, Adembri C, Brunelleschi S,
Ferrari E, Novelli GP. Neutrophils as mediators of human
skeletal muscle ischaemia reperfusion syndrome. Hum Pathol
1992; 23:627–634.
44 Lindsay TF, Memari N, Ghanekar A, Walker P, Romaschin A.
Rupture of abdominal aortic aneurysm causes priming of
phagocytic oxidative burst. J Vasc Surg 1997; 25:599–610.
45 Formigli L, Manneschi LI, Adembri C, Orlandini SZ,
Pratesti C, Novelli GP. Expression of E-selectin in ischaemic
and reperfused human skeletal muscle. Ultrastr Pathol 1995; 19:
193–200.
46 Novelli GP, Adembri C, Gandini E et al. Vitamin E protects
human skeletal muscle from damage during surgical ischaemia-
reperfusion. Am J Surg 1997; 173:206–209.
47 Rowlands TE, Homer-Vanniasinkam S. Pro- and anti-inflam-
matory cytokine release in open versus endovascular repair of
AAA. Br J Surg 2001; 88:1335–1340.
48 Ernst CB, Hagihara PF, Daugherty ME, Griffen WO. Inferior
mesenteric artery stump pressure: a reliable index for safe IMA
ligation during abdominal aortic aneurysmectomy. Ann Surg
1978; 187:641–646.
49 Piotrowski JJ, Ripepi AJ, Yuhas JP et al. Colonic ischaemia: the
Achilles heel of ruptured aortic aneurysm repair. Am Surg 1996;
62:557–561.
50 Bjorck M, Troeng T, Bergqvist D. Risk-factors for intestinal
ischaemia after aortoiliac surgery. A combined cohort and case–
control study of 2824 operations. Eur J Vasc Endovasc Surg 1997;
13:531–539.
51 Welch M, Baguneid MS, McMahon RF et al. Histological study
of colonic ischaemia after aortic surgery. Br J Surg 1998; 85:
1095–1098.
52 BjorckM, Lindberg F, BromanG, Bergqvist D. pHi monitoring
of the sigmoid colon after aortoiliac surgery. A five-year
prospective study. Eur J Vasc Endovasc Surg 2000; 20:273–280.
53 Yassin MMI, Barros D’Sa AAB, Parks TG et al. Lower limb IRI
alters GI structure and function. Br J Surg 1997; 84:1425–1429.
54 Cabie A, Farkas JC, Fitting C et al. High levels of portal TNFa
during abdominal aortic surgery in man. Cytokine 1993; 5:
448–453.
55 Corson RJ, Paterson IS, O’Dwyer STet al. Lower limb ischaemia
and reperfusion alters gut permeability. Eur J Vasc Surg 1992; 6:
158–163.
56 Yassin MMI, Barros D’Sa AAB, Parks TG et al. Lower limb IRI
causes endotoxaemia and endogenous antiendotoxin antibody
consumption but not bacterial translocation. Br J Surg 1998; 85:
785–789.
57 Watson RWG, Redmond HP, McCarthy J, Burke PE,
Bouchier-Hayes D. Exposure of the peritoneal cavity to air
regulates early inflammatory responses to surgery in a murine
model. Br J Surg 1995; 82:1060–1065.
58 Baigrie RJ, Lamont PM, Morris PJ. Portal endotoxin and
cytokine responses to abdominal aortic surgery. Br J Surg 1992;
79:1235.
59 Lau LL, Halliday MI, Lee B, Hannon RJ et al. Intestinal
manipulation during elective aortic aneurysm surgery leads to
portal endotoxaemia and mucosal barrier dysfunction. Eur J Vasc
Endovasc Surg 2000; 19:619–624.
60 Soong CV, Blair PHB, Halliday MI et al. Endotoxaemia, the
generation of cytokines and their relationship to intramucosal
acidosis of the sigmoid colon in elective AAA repair. Eur J Vasc
Surg 1993; 7:534–539.
61 Green M, Hickey NC, Crowe A, Curry P, Paterson IS,
Shearman CP. Interleukin 6 production by the colon is a
response to sigmoid ischaemia. Br J Surg 1994; 81:615.
62 Murray CE, Jennings RB, Reimer KA. Preconditioning with
ischaemia: a delay of lethal cell injury in ischaemic myocardium.
Circulation 1986; 74:1124–1136.
63 Bushell AJ, Klenerman L, Taylor S, Davies H, Grierson I,
Helliwell TR, Jackson MJ. Ischaemic preconditioning of
skeletal muscle. 1. Protection against the structural changes
induced by ischaemia/reperfusion injury. J Bone Joint Surg—Br
Vol 2002; 84(8):1184–1188.
64 Papanastasiou S, Estdale SE, Homer-Vanniasinkam S,
Mathie RT. Protective effect of preconditioning and adenosine
pretreatment in experimental skeletal muscle reperfusion injury.
Br J Surg 1999; 86:916–922.
65 Loke KE, Woodman OL. Effect of ischaemic preconditioning on
vascular dysfunction induced by ischaemia and reperfusion in
rat hindquarters. Cardiovasc Res 1996; 32:1081–1087.
66 Pang CY, Yang RZ, Zhong A, Xu N, Boyd B, Forrest CR. Acute
ischaemic preconditioning protects against skeletal muscle
infarction in the pig. Cardiovasc Res 1995; 29:782–788.
67 Harkin DW, Barros D’Sa AA, McCallion K, Hoper M,
Campbell FC. Ischemic preconditioning before lower limb
ischemia-reperfusion protects against acute lung injury. J Vasc
Surg 2002; 35:1264–1273.
68 Formigli L, Ibba Manneschi L, Tani A et al. Vitamin E prevents
neutrophil accumulation and attenuates tissue damage in
ischemic-reperfused human skeletal muscle. Histol Histopathol
1997; 12:663–669.
69 Wijnen MH, Roumen RM, Vader HL, Goris RJ. A multi-
antioxidant supplementation reduces damage from ischaemia
reperfusion in patients after lower torso ischaemia. A random-
ised trial. Eur J Vasc Endovasc Surg 2002; 23:486–490.
70 Wijnen MH, Vader HL, Roumen RM. Multi-antioxidant
supplementation does not prevent an increase in gut perme-
ability after lower torso ischemia and reperfusion in humans. Eur
Surg Res 2002; 34:300–305.
71 Wijnen MH, Vader HL, Van DenWall Bake AW, Roumen RM.
Can renal dysfunction after infra-renal aortic aneurysm repair be
modified by multi-antioxidant supplementation? Cardiovasc Surg
2002; 43:483–488.
72 Sun Z, Wang X, Lasson A, Bojesson A, Annborn M,
Andersson R. Effects of inhibition of PAF, ICAM-1 and
PECAM-1 on gut barrier failure caused by intestinal ischemia
and reperfusion. Scand J Gastroenterol 2001; 36:55–65.
73 Gurule DM, Larson RS. Amelioration of ischemia-reperfusion
M. G. A. Norwood et al.244
Eur J Vasc Endovasc Surg Vol 28, September 2004
injury with cyclic peptide blockade of ICAM-1. Am J Physiol 2003;
284:H1260–H1268.
74 Ferrante RJ, Hobson II RW, Miyasaka M, Granger DN,
Duran WN. Inhibition of white blood cell adhesion at reper-
fusion decreases tissue damage in postischemic striated muscle.
J Vasc Surg 1996; 24:187–193.
75 Koike K, Moore EE, Moore FA. CD11b blockade prevents lung
injury despite neutrophil priming after gut ischemia/reper-
fusion. J Trauma 1995; 39:23–28.
76 Weisman HF, Bartow T, Leppo MK et al. Recombinant soluble
CR1 suppressed complement activation, inflammation, and
necrosis associated with reperfusion of ischaemic myocardium.
Trans Assoc Am Phys 1990; 103:64–72.
77 Reinhart K, Menges T, Gardlund B et al. Randomized,
placebo-controlled trial of the anti-tumor necrosis factor anti-
body fragment afelimomab in hyperinflammatory response
during severe sepsis: the RAMSES study. Crit Care Med 2001;
29:765–769.
78 Remick DG. Cytokine therapeutics for the treatment of sepsis:
why has nothing worked? Curr Pharm Des 2003; 9:75–82.
79 Ondiveeran HK, Fox-Robichaud A. New developments in the
treatment of ischemia/reperfusion injury. Curr Opin Invest Drugs
2001; 2:783–791.
Accepted 30 March 2004
Available online 15 June 2004
Regional Inflammatory Responses in AAA Repair 245
Eur J Vasc Endovasc Surg Vol 28, September 2004
